PURPOSE PRESIDER/PRESENTER(s)

Dr. Nancy Bennett (ACIP Chair)

Dr. Amanda Cohn (ACIP Executive Secretary; CDC)

8:30 Influenza Vaccines 

Introduction

VE update

Dr. Chip Walter (ACIP, WG Chair)

Dr. Brendan Flannery (CDC/NCIRD), Dr. Yun Lu (FDA) 

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. Gregg Sylvester (Seqirus)

Dr. Lisa Grohskopf (CDC/NCIRD)

Dr. Lisa Grohskopf (CDC/NCIRD)

10:40

11:00 Anthrax Vaccines

Introduction

GRADE 

Summary of Work Group considerations and proposed policy 

options

Public comment

Vote

Dr. David Stephens (ACIP, WG Chair)

Dr. William Bower (CDC/NCEZID)

Dr. William Bower (CDC/NCEZID)

Dr. William Bower (CDC/NCEZID)

12:15

1:30 HPV Vaccines

Introduction

Current issues and background

HPV vaccine in mid-adults: results from clinical studies 

Considerations and Work Group plans 

Dr. Peter Szilagyi (ACIP, WG Chair)

Dr. Lauri Markowitz (CDC/NCIRD)

Dr. Alain Luxembourg (Merck)

ACIP HPV Vaccines Workgroup

2:40 Update on NITAGS

Introduction

Global NITAG activities and the GNN

Dr. Abigail Shefer (CDC/GID)

Dr. Joachim Hombach (Executive Secretary SAGE, WHO 

IVB)

3:10

3:40 Mumps Vaccine

Introduction

Current US mumps epidemiology and CDC guidance for 

implementation of the ACIP recommendation for a 3rd dose of 

MMR vaccine during outbreaks

Dr. Kelly Moore (ACIP, WG Chair)

Dr. Mariel Marlow (CDC/NCIRD)

4:10 Zoster Vaccine

Introduction

Herpes Zoster vaccination: evaluation update

Dr. Edward Belongia (ACIP, WG Chair)

Dr. Kathleen Dooling (CDC/NCIRD)

4:35

4:50 Adjourn

Information 

& 

Discussion

Information

Information 

& 

Discussion

Public Comment

Information 

Wednesday, June 20

8:00 Welcome & Introductions

Break

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center, Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30329 

June 20-21, 2018

AGENDA ITEM

Information 

& 

Discussion

Vote

Lunch

2017-2018 influenza season vaccine safety update

Narcolepsy following adjuvanted monovalent pandemic H1N1 

influenza vaccines: Results of the SOMNIA study

Study results of an adjuvanted Quadravalent Influenza vaccine 

in young children 

2018-19 recommendations

Public Comment

Vote

Break

Information 

& 

Discussion

Vote

This document has been archived for historical purposes. (6/18/2018)
Information Dr. Nancy Messonnier (CDC/NCIRD); Ex Officio 

Members

8:30 Japanese Encephalitis Vaccine

Introduction

JE-VC GRADE

Comparative analysis background

Comparative analysis of JE vaccination strategies

Summary and conclusions

Dr. Chip Walter (ACIP, WG Chair)

Dr. Susan Hills (CDC/NCEZID)

Dr. Marc Fischer (CDC/NCEZID)

Dr. Martin Meltzer (CDC)

Dr. Susan Hills (CDC/NCEZID)

10:30

11:00 Pneumococcal Vaccines

Introduction

Safety of PCV13 in adults aged >65 years old

Pneumonia Incidence in the US

Pneumococcal carriage, invasive disease, and hospitalizations 

following community acquired pneumonia (CAP) among Native 

American populations

Racial disparities in invasive pneumococcal disease and PCV13 

impact

Overview of the Evidence to Recommendations Framework for 

the ongoing review of the PCV13 recommendation for adults 

≥65 years old

Dr. Grace Lee (ACIP, WG Chair)

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. David Swerdlow (Pfizer)

Dr. Laura Hammitt, Director, Infectious Disease 

Prevention Program, Center for American Indian 

Health

Dr. Almea Matanock (CDC/NCIRD)

Dr. Almea Matanock (CDC/NCIRD)

12:30 Information Dr. Jeanne Santoli (CDC/NCIRD)

12:35 Public Comment

12:45 Adjourn

Acronyms

CDC

CMS

DoD

DVA

FDA

GRADE

HRSA

IHS

JE-VC

NCHHSTP

NCIRD

NCEZID

NCI 

NIH

NITAG 

NVPO

PCV13

VFC

WG

WHO IVB World Health Organization, Immunization, Vaccines and Biologicals

Information 

& 

Discussion

Break

Thursday, June 21

8:00 Agency Updates & Unfinished Business

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NIH, NVPO

Work Group

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

Vaccines for Children

Health Resources and Services Administration

Indian Health Service

National Vaccine Program Office

National Center for Emerging and Zoonotic Diseases [of CDC/OID]

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

Vero cell culture-derived Japanese encephalitis 

13-valent pneumococcal conjugate vaccine 

National Cancer Institute

National Institutes of Health

National Immunization Technical Advisory Groups

Grading of Recommendations Assessment, Development and Evaluation

Centers for Medicare and Medicaid Services 

Centers for Disease Control & Prevention

Food and Drug Administration

Department of Veterans Affairs

Department of Defense

Vaccine Supply

Information 

& 

Discussion

This document has been archived for historical purposes. (6/18/2018)